NUZ neurizon therapeutics limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-616

  1. 3,043 Posts.
    lightbulb Created with Sketch. 2061
    Looks like you were spot on in your prediction DAAC preparations for progressing the dogies is continuing with MND on track and Covid to kick off shortly after.

    Looks like lots of boring but important details are being tied up in the back ground that will lead to an exciting future.

    Have to say though, this would be a good time to add a bit of razzmatazz, get the message out followed by a zoom presentation and maybe even tell what what their target is in reaching a commercial deal with the canine negotiations. Eg, we want ? as a result. Doesn't have to be bigger than Ben Hur just a bit more polished.

    Without a deep understanding of the company I wonder if this would be a good time to sell off Epichem to cash up for a big last push. They could still contract to PAA to do work.

    Wow, the next 6 months could be pretty amazing. [Or not]


    Pete
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $81.23M
Open High Low Value Volume
16.5¢ 17.0¢ 16.0¢ $54.17K 328.2K

Buyers (Bids)

No. Vol. Price($)
7 98500 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 23653 4
View Market Depth
Last trade - 13.18pm 15/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.